CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-16 | Walker Neal President and CEO | Shares withheld for taxes | −782 | $1.80 | $1K | 919,596 |
| 2019-12-16 | Walker Neal President and CEO | Option exercise · Restricted Stock Units | −3,033 | 3,034 | ||
| 2019-12-16 | Ruffo Frank Chief Financial Officer | Option exercise | +1,300 | 166,276 | ||
| 2019-12-16 | Ruffo Frank Chief Financial Officer | Shares withheld for taxes | −370 | $1.80 | $666 | 165,906 |
| 2019-12-16 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted Stock Units | −1,300 | 1,300 | ||
| 2019-12-16 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +1,733 | 83,945 | ||
| 2019-12-16 | Ali-Jackson Kamil Chief Legal Officer | Shares withheld for taxes | −497 | $1.80 | $895 | 83,448 |
| 2019-12-16 | Ali-Jackson Kamil Chief Legal Officer | Option exercise · Restricted Stock Units | −1,733 | 1,734 | ||
| 2019-10-30 | Gordon David N. Chief Medical Officer | Grant or award · Restricted stock units | +175,000 | 175,000 | ||
| 2019-07-02 | GOWEN MAXINE Director | Grant or award · Stock option (right to buy) | +16,000 | 16,000 | ||
| 2019-07-02 | Gordon David N. Chief Medical Officer | Option exercise | +6,000 | 6,000 | ||
| 2019-07-02 | Gordon David N. Chief Medical Officer | Shares withheld for taxes | −1,648 | $2.34 | $4K | 4,352 |
| 2019-07-02 | Gordon David N. Chief Medical Officer | Option exercise · Restricted Stock Units | −6,000 | 18,000 | ||
| 2019-06-27 | Flynn James E 10% owner | Sale | −108,674 | $2.69 | $292K | 964,101 |
| 2019-06-27 | Flynn James E 10% owner | Sale | −590,801 | $2.69 | $1.6M | 3,159,165 |
| 2019-06-26 | Flynn James E 10% owner | Sale | −352 | $4.50 | $2K | 1,072,775 |
| 2019-06-26 | Flynn James E 10% owner | Sale | −1,352 | $4.50 | $6K | 3,749,966 |
| 2019-06-25 | Flynn James E 10% owner | Sale | −10,634 | $4.51 | $48K | 1,073,127 |
| 2019-06-25 | Flynn James E 10% owner | Sale | −40,850 | $4.51 | $184K | 3,751,318 |
| 2019-06-24 | Flynn James E 10% owner | Sale | −13,063 | $4.52 | $59K | 1,083,761 |
Page 40 of 47 · 928 trades